Director, President and CEO · Century Therapeutics, Inc. · Common Stock
Side
BUY
Value
$30K
Shares
52.0K
Price
$0.58
Executed
Dec 12, 2025
Disclosed
Dec 16, 2025
Disclosure timeline4 days from execution to publication · legal deadline 2 business days
Dec 12 executedDec 16, 2025 disclosed
IPSC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Disclosed 2 business days after execution (deadline: 2)
Historical behavior+4 / 15
2 prior trades recorded in this security
Frequency & clustering+5 / 15
1 other actor traded the same direction within 14 days
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Pfeiffenberger Brent filed this Form 4 reporting a open-market purchase of IPSC on Dec 12, 2025. It became public on Dec 16, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, President and CEO
Pfeiffenberger Brentcik:0002001162
Issuer
Century Therapeutics, Inc.cik:0001850119
Revision history · 0
No field has changed since this record was first ingested.
